Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
basic toxicokinetics in vivo
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Only summary of data available but scientifically acceptable published data from an acknowledged source (EU Risk Assessment Report) (Data suitable for read-across).

Data source

Referenceopen allclose all

Reference Type:
secondary source
Title:
European Union Risk Assessment Report dimethyldioctadecylammonium chloride
Author:
European Chemicals Bureau, Institute for Health and Consumer Protection
Year:
2002
Reference Type:
publication
Title:
Metabolism of cutaneously applied surfactants.
Author:
Drotman R.B.
Year:
1977
Bibliographic source:
Cutaneous Toxicity, 3, 95-109

Materials and methods

Objective of study:
absorption
Principles of method if other than guideline:
The 14C-labelled test substance was applied to the back of 4 rabbits. Radioactivity at the application site, in urine, faeces, exhaled carbon dioxide, other skin and cage wash was determined over a 72 hour period.
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Dimethyldioctadecylammonium chloride
EC Number:
203-508-2
EC Name:
Dimethyldioctadecylammonium chloride
Cas Number:
107-64-2
Molecular formula:
C38H80N.Cl
IUPAC Name:
N,N-dimethyl-N-octadecyloctadecan-1-aminium chloride
Details on test material:
- Name of test material (as cited in study report): Dioctadecyldimethylammonium chloride (DODMAC)
Radiolabelling:
yes
Remarks:
14C

Test animals

Species:
rabbit
Strain:
not specified
Sex:
not specified

Administration / exposure

Route of administration:
dermal
Vehicle:
not specified
Details on exposure:
TEST SITE
- Area of exposure: on the back, 5-8 cm area
Duration and frequency of treatment / exposure:
single application
Doses / concentrations
Remarks:
Doses / Concentrations:
10 mg
No. of animals per sex per dose / concentration:
4
Control animals:
no
Details on dosing and sampling:
PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled: urine, faeces, skin at the application site, other skin, cage washes, exhaled carbon dioxide

Results and discussion

Toxicokinetic / pharmacokinetic studies

Details on absorption:
Most of the radioactivity remained at the site of application (88 ± 2.3%).
Details on distribution in tissues:
Only traces of radioactivity were detected at other skin sites (0.2%).
Details on excretion:
Only traces of administered radioactivity were detected over a 72 h-period in urine (0.15 %), faeces (0.16 %), exhaled carbon dioxide (0.27 %) and cage wash (0.3%).

Metabolite characterisation studies

Metabolites identified:
not measured

Applicant's summary and conclusion